Tumor invasion requires disulfide bond reduction of the extracellular matrix
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Medecine sciences : M/S - 37(2021), 4 vom: 27. Apr., Seite 322-324 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
La réduction des ponts disulfures de la matrice extracellulaire - Un prérequis à l’invasion par les cellules tumorales |
|---|
| Beteiligte Personen: |
Ros, Manon [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 15.11.2021 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1051/medsci/2021025 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324622139 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324622139 | ||
| 003 | DE-627 | ||
| 005 | 20231227130508.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1051/medsci/2021025 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1224.xml |
| 035 | |a (DE-627)NLM324622139 | ||
| 035 | |a (NLM)33908847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Ros, Manon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tumor invasion requires disulfide bond reduction of the extracellular matrix |
| 246 | 3 | 3 | |a La réduction des ponts disulfures de la matrice extracellulaire - Un prérequis à l’invasion par les cellules tumorales |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.11.2021 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Collagen Type I |2 NLM | |
| 650 | 7 | |a Disulfides |2 NLM | |
| 650 | 7 | |a Calnexin |2 NLM | |
| 650 | 7 | |a 139873-08-8 |2 NLM | |
| 650 | 7 | |a N-Acetylgalactosaminyltransferases |2 NLM | |
| 650 | 7 | |a EC 2.4.1.- |2 NLM | |
| 650 | 7 | |a GLA protein, human |2 NLM | |
| 650 | 7 | |a EC 3.2.1.22 |2 NLM | |
| 650 | 7 | |a alpha-Galactosidase |2 NLM | |
| 650 | 7 | |a EC 3.2.1.22 |2 NLM | |
| 650 | 7 | |a Protein Disulfide-Isomerases |2 NLM | |
| 650 | 7 | |a EC 5.3.4.1 |2 NLM | |
| 650 | 7 | |a PDIA3 protein, human |2 NLM | |
| 650 | 7 | |a EC 5.3.4.1. |2 NLM | |
| 700 | 1 | |a Bard, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Saltel, Frédéric |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medecine sciences : M/S |d 1996 |g 37(2021), 4 vom: 27. Apr., Seite 322-324 |w (DE-627)NLM08683102X |x 1958-5381 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2021 |g number:4 |g day:27 |g month:04 |g pages:322-324 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1051/medsci/2021025 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2021 |e 4 |b 27 |c 04 |h 322-324 | ||